There is clearly a demand for more rapid and reliable laboratory methods for the diagnosis of Mycobacterium tuberculosis infections for public health and therapeutic reasons worldwide (5) . The introduction of the radiometric BACTEC system represented a major improvement in the cultivation of mycobacteria by providing rapid detection and a high recovery rate, usually within 10 to 20 days (21) . Species-specific nucleic acid probes have significantly improved the prospects for rapid confirmation of culture results for several mycobacterial species (12) . The use of DNA amplification techniques such as PCR for species identification of mycobacteria, particularly M. tuberculosis, from early BACTEC cultures has also been favorably explored (9) . Still, days to weeks may be required for sufficient growth for identification and subsequent susceptibility testing, particularly in paucibacillary samples.
Several groups have previously validated PCR assays for the identification of M. tuberculosis complex directly in clinical specimens (7, 10, 11, 13) . Several nucleic acid targets, such as the 16S rRNA gene (6) , insertion elements (11, 25) , and the genes encoding the 32-, 38-, and 65-kDa proteins (7, 25, 26) , have rendered high sensitivity and representative species-specific differentiation. Nucleic acid amplification techniques other than PCR, such as transcription-mediated amplification of RNA (15) and, more recently, strand displacement (29) and Q␤ replicase probe amplification assays (1) , are also being used.
We evaluated the LCx MTB Assay (Abbott Laboratories, Chicago, Ill.) for detection of the M. tuberculosis complex directly in clinical specimens. In this assay, detection of the M. tuberculosis complex is performed by specific probe amplification employing the ligase chain reaction (LCR) (3, 4, 18) . The target DNA to be amplified was the gene encoding the 38-kDa protein, designated protein antigen b (Pab) (2) . In LCR amplification, the sample to be investigated is added to a reaction mixture consisting of four oligonucleotide probes, thermostable ligase and polymerase, and individual nucleotides in buffer. The four oligonucleotide probes are designed in pairs to hybridize to complementary single-stranded M. tuberculosis target sequences exposed in the sample preparation. When a pair of probes has hybridized to the target sequence on a single strand of DNA, there is a gap of three nucleotides between the probes. Polymerase acts to fill in this gap with the nucleotides in the LCR mixture. Once the gap is filled, ligase can covalently join the pair of probes to form an amplification product that is complementary to the original target sequence and can itself serve as a target in subsequent rounds of amplification. Detection of Chlamydia trachomatis DNA in clinical samples, including male and female urine, by LCR has been favorably utilized (14, 23) , and recently, in parallel to our study, the LCR approach has been used to detect M. tuberculosis in respiratory specimens (3) . The aim of our study was to establish whether this test is useful for direct detection of the M. tuberculosis complex in clinical samples in patients in Norway.
MATERIALS AND METHODS

Materials.
Routine clinical specimens submitted for cultivation of mycobacteria from three hospitals in the Oslo region were processed by standard procedures. The specimens from areas of the body inhabited by normal flora were decontaminated by the N-acetyl-L-cysteine (NALC)-NaOH method (17) . Two volumes of NALC-NaOH solution (2% NaOH, 1.45% sodium citrate, 0.5% NALC) were mixed well with the specimens and allowed to digest for 15 to 20 min at room temperature (24) . Ten volumes of 10 mM phosphate-buffered saline (PBS) (pH 6.8) was added for dilution before centrifugation at 3,000 ϫ g for 15 min. The sediment was resuspended in 1 to 2 ml of PBS. Four hundred eightytwo specimens from 457 patients were included in the study. Four hundred sixty-five specimens were obtained from the respiratory tract (sputum or bronchoalveolar lavage fluid). The 17 extrapulmonary clinical specimens investigated were obtained from abscess material associated with lymphadenitis (n ϭ 5), spinal fluid (n ϭ 2), skin biopsy samples (n ϭ 3), pleural fluid (n ϭ 4), and urine (n ϭ 3).
Direct microscopy. Smears were prepared, Ziehl-Neelsen stained, and examined for acid-fast bacilli (AFB) by microscopy.
Culture protocol. BACTEC Middlebrook 12B vials (Becton Dickinson Diagnostic Instruments, Sparks, Md.) (21, 24) were inoculated with 0.5 ml of each specimen. The 12B vials were monitored by using the BACTEC 460 radiometric reader (Becton Dickinson) on a regular basis for 6 weeks. Monitoring was performed three times weekly for the first 3 weeks, then twice weekly for the following 3 weeks. Once a 12B vial attained a growth index of Ն100, the presence of AFB was confirmed by Ziehl-Neelsen staining. The LCR assay was incorporated into the laboratory routine without any change in culture practices, and specimens were processed 5 or 6 days/week.
Culture identification. Hybridization assays were performed directly on lysed AFB with commercially available nucleic acid probes for M. tuberculosis complex and Mycobacterium avium-M. intracellulare complex (MAC) (Accuprobe; Gen Probe, San Diego, Calif.) (12) . Selected cultures were also subjected to tests for niacin, nitrate reductase, and tiophene-2-carbonic acid resistance (22) . Mycobacterial species other than M. tuberculosis complex and MAC were identified by conventional procedures (19, 22) . Strains of Mycobacterium marinum and Mycobacterium ulcerans were identified by testing for the presence of photochromogenicity and heat-stable catalase activity, respectively (19, 20) .
LCR analysis. The LCx MTB Assay (Abbott) was performed according to the manufacturer's recommendations, as follows.
(i) Specimen preparation. Five hundred microliters of decontaminated clinical specimen was added to an LCx respiratory specimen tube containing 50 mg of 150-to 212-m-diameter acid-washed glass beads and 900 l of buffer, pH 4.1. The tube was vortex mixed for 5 s and centrifuged at 1,500 ϫ g for 10 min at room temperature. The supernatant was carefully removed, and washing of the pellet was performed with 1 ml of LCx respiratory specimen resuspension buffer. Centrifugation was repeated, the supernatants were removed, and the pellet was dissolved in 0.5 ml of respiratory specimen resuspension buffer by vortex mixing and was incubated at 95°C for 20 min. The biopsy samples were pretreated with proteinase K (50 g/ml end concentration) at 37°C for 1 h before lysis. Following heat inactivation, the samples were mechanically lysed in the LCx Lysor (Abbott) for 10 min. After cooling and centrifugation at Ͼ9,000 ϫ g for 2 min, 100 l of each sample was subjected to amplification. One positive control containing M. tuberculosis DNA and one negative control containing salmon testes DNA were included in each experiment.
(ii) LCR amplification. Four M. tuberculosis species-specific oligonucleotide probes derived to correspond to a highly conserved region of the single-copy chromosomal gene encoding Pab of M. tuberculosis were used to amplify a 44-bp fragment (bases 347 to 390 of the M. tuberculosis gene encoding Pab) (2) . The four M. tuberculosis complex-specific oligonucleotides employed were probe 1 (5Ј-AACCTGTGGGGTCCGGCCTTT-3Ј), probe 2 (5Ј-TTGGACACCCCAG GCCGG-3Ј), probe 3 (5Ј-GAGAGGTATCCGAACGTCAC-3Ј), and probe 4 (5Ј-GTGACGTTCGGATACCTCTCCAC-3Ј). The individual oligonucleotides were prelabelled with either a capture hapten or a detection hapten. One hundred microliters of each sample and the negative and positive controls were added to 100 l of LCx MTB Assay amplification mixture containing buffer, the four oligonucleotides, 1.0 M (each) dATP and dCTP, and thermostable DNA polymerase and thermostable ligase (Abbott). The samples were amplified for 37 cycles of 1 s at 94°C, 1 s at 64°C, and 40 s at 69°C in an LCx thermal cycler.
(iii) Detection reaction. After amplification, the tubes were pulse centrifuged and manually transferred to LCx reaction cells. Detection was performed by a MEIA assay in an LCx analyzer (Abbott). In the LCx analyzer, an aliquot from each amplification vial was automatically transferred to an incubation well containing microparticles coated with anti-capture hapten. This reaction mixture was automatically transferred to a glass fiber matrix which binds the microparticle complexes irreversibly. After a wash to remove unligated probe, the bound microparticle complexes were incubated with antihapten-alkaline phosphatase conjugate, which binds to the detection haptens. The antibody conjugate was detected by the substrate 4-methylumbelliferyl phosphate, which is dephosphorylated by alkaline phosphatase to produce a fluorescent molecule, 4-methylumbelliferone, which was monitored by the MEIA optical assembly (18) . By relating the LCx MTB Assay results for the specimens to the cutoff value (CO), the presence or absence of M. tuberculosis complex DNA was determined. The CO rate was the mean rate of the positive calibrator controls multiplied by 0.30. The S/CO value was determined by calculating the ratio of the sample rate (S) to the CO. A clinical specimen with an S/CO reading equal to or greater than 1 was considered positive, and a specimen with an S/CO reading less than 1 was negative for the presence of M. tuberculosis DNA.
(iv) Inactivation of amplified LCR products. After the detection reaction, each vial was subjected to automatic inactivation of nucleic acids in the LCx analyzer.
Inactivation was performed by using a two-reagent chemical inactivation system consisting of a chelated metal complex and an oxidizing agent that were delivered into the LCx reaction cells. This inactivation was performed to reduce the possibility of false-positive results due to contamination.
RESULTS
Detection of mycobacteria by culture. In total, 132 of 482 specimens (27.4%) were positive for mycobacteria by culture. Of these, 118 (24.3%) were M. tuberculosis complex isolates from 92 patients ( Table 1) . Such a high rate of positivity by culture is not representative of the low tuberculosis incidence in the population of Norway (27) , but in this investigation as many culture-positive samples as possible were included during a time frame of 9 months in 1996. The 14 nontuberculous mycobacterial cultures were MAC (n ϭ 10), Mycobacterium malmoense (n ϭ 2), M. marinum (n ϭ 1), and M. ulcerans (n ϭ 1).
Detection of mycobacteria by microscopy. When analyzed by Ziehl-Neelsen staining in direct microscopy, 88 of the 118 M. tuberculosis complex culture-positive specimens (74.6%) were positive for AFB ( Table 1) . Eight of the 14 NTM culturepositive specimens were positive for AFB by Ziehl-Neelsen staining.
Detection of M. tuberculosis complex by LCR. The 482 clinical specimens were tested for the presence of the M. tuberculosis complex by the nucleic acid amplification method LCR. In total, 106 of the 118 specimens which yielded the M. tuberculosis complex by culture were positive for M. tuberculosis complex DNA by LCR (Table 1) . LCR was positive for an additional eight specimens, from five patients, which were negative by culture. The overall sensitivity, specificity, and positive and negative predictive values of this particular LCR test in comparison with culture and clinical criteria were 90.2, 99.2, 97.4, and 96.7%, respectively ( Table 1 ). The sensitivity of the LCR test in comparison with culture, clinical criteria, and information on antituberculosis treatment was 96.7% for smear-positive specimens and 72.0% for smear-negative specimens (Table 1). The sensitivity, specificity, and positive and negative predictive values of BACTEC culture in comparison with the LCR test and the criteria listed above were 95.9, 100, 100, and 98.6%, respectively.
Some of the specimens initially yielding discrepant results by culture, microscopy, and LCR were resolved by the analysis of another specimen from the same patient and/or information about clinical criteria and treatment (Table 2) . Five specimens from patients whose sputum specimens were culture negative but M. tuberculosis complex LCR positive had other LCRpositive samples, a past history of tuberculosis, and/or clinical response to recent anti-tuberculosis chemotherapy (Table 2) . Two specimens from one patient taken at different time points were repeatedly LCR positive but negative by M. tuberculosis complex culture, direct microscopy, and PCR (Table 2 ). Another specimen was LCR positive with AFB detection by microscopy, but this specimen was negative by BACTEC culture and the patient had no significant signs of tuberculous infection and was not treated as such. Some of the discrepant specimens were also analyzed by PCR (Cobas Amplicor; Roche), but this comparison was incomplete due to lack of sample material and the fact that the Cobas PCR assay was introduced in our laboratory when the LCR trial was almost completed.
From some patients, more than one specimen was taken during the course of diagnosis and early treatment. Nucleic acid from M. tuberculosis complex was detected for up to 2 or 3 weeks after initiation of treatment (three samples investigated). Even though the Abbott LCx MTB Assay is validated only for respiratory specimens, we extended our study to include 17 nonrespiratory specimens. Only one of these samples (from a patient with lymphadenitis) was positive for M. tuberculosis complex by both culture and LCR. However, this was a particularly important specimen, as it was the second case of multidrug-resistant M. tuberculosis detected in Norway.
No positive result for M. tuberculosis complex was obtained by the Abbott LCx MTB Assay for the 14 specimens which were positive for nontuberculous mycobacteria grown in the BACTEC 12B medium. In particular, specificity testing was performed with regard to the species M. marinum and M. ulcerans, which are the mycobacterial species most closely related to M. tuberculosis complex (28) . First, cultures and DNAs from two M. marinum and M. ulcerans strains tested negative for M. tuberculosis by LCR. Second, two skin biopsy samples which previously were culture positive for M. marinum and M. ulcerans were included in the LCR assay after protease pretreatment and then tested negative.
DISCUSSION
In comparison with culture, the sensitivity of LCR in the detection of M. tuberculosis complex was 96.7% for smearpositive samples and 72.0% for smear-negative samples, respectively, and 90.2% for all samples (Table 1 ). In comparison with previously published studies for direct detection of M. tuberculosis by PCR and LCR, other groups have found that the sensitivity of these assays, compared with culture, ranged from 82 to 92% for smear-positive and smear-negative samples combined (1, 7, 10, 11, 25) . In this study, eight samples from five patients were M. tuberculosis complex culture negative and LCR positive and could, as such, be strictly regarded as false positive. But when other factors were taken into account for evaluating the patient as M. tuberculosis complex positive by having other samples be positive by culture and/or LCR or other factors indicating tuberculosis (clinical signs, X-ray findings, and/or treatment), five of these samples were resolved as M. tuberculosis complex positive. After resolution of the results according to these criteria, three samples remained as authentic false positives. One sample was LCR positive, with AFB detection by microscopy, but this specimen was negative by BACTEC culture and the patient had no significant signs of tuberculous infection. The other two samples were taken at different time points from one patient and remained repeatedly and unexplainably LCR positive. These were both bronchoalveolar lavage samples. As such, they had an increased chance of being contaminated by M. tuberculosis complex (DNA) from an inadequately cleaned bronchoscope (16) , but this explanation seems unlikely for two independent occasions and probably is not satisfactory given the low tuberculosis incidence in the population of Norway.
The NALC procedure is the decontamination method recommended by the manufacturer (Abbott) of the LCx MTB Assay, and it is also used for other amplification techniques (13, 15, 27) . Our laboratory used the NALC decontamination procedure on all clinical samples indicated, while the other hospitals submitting samples for LCR testing had at times already decontaminated the samples by the sodium dodecyl sulfate method. Samples decontaminated by the sodium dodecyl sulfate method were washed twice with PBS (pH 7.4) and then subjected to LCR analysis with good results. In our hands, the LCR assay worked just as well directly on respiratory specimens which were not subjected to decontamination (seven M. tuberculosis complex-positive samples [unpublished re- 
The lack of sensitivity of culture could be due to less optimized culture techniques using only BACTEC detection and not including solid media (21) . Possibly, recently documented batches of BACTEC vials with reduced performance in cultivating both M. tuberculosis complex and nontuberculous mycobacteria might be involved (8) .
The sample distribution included in this study (culture positivity rate, 27.4%) is not representative of the low tuberculosis incidence of the population in Norway, where the total mycobacterial culture positivity rate usually averages only 4 to 5%, of which M. tuberculosis cultures make up 2 to 2.5% (27) . However, our aim in this particular study was to include as many M. tuberculosis-positive samples as possible during a certain time for sensitivity and specificity testing of the LCx MTB Assay.
The specificity of the Abbott LCx MTB Assay was challenged by the inclusion of strains and clinical samples of M. marinum and M. ulcerans. These samples (cultures, DNAs, and biopsy samples) all gave clearly negative results in the LCx MTB Assay. This LCR test therefore appears to be most specific for the M. tuberculosis complex with the gene encoding Pab as the amplification target.
One positive feature of the LCx MTB Assay is the very thorough and well-adjusted procedure for sample preparation and lysis. The sample pretreatment procedure employed (including as much as 0.5 ml of the specimen in each vial, optimized washing, buffering, and lysis of the sample and also providing a clearly visible pellet) clearly facilitates direct detection of M. tuberculosis. False-positive LCR results were reduced by chemical destruction of amplified products after detection. These major features probably account for the relatively high sensitivity and specificity of the LCx MTB Assay. These features, in addition to careful laboratory precautions in sample processing and work habits, have minimized the occurrence of false-positive and negative LCR results.
An important factor lacking in this LCR assay is an internal amplification control, which should be included in amplification assays even in low-incidence populations. The option of doing an LCR "spiking" with M. tuberculosis DNA to assay for inhibitory factors in addition to the actual test itself adds workload and cost, as when such an internal control is included in any amplification kit.
Some of the samples in this study were also analyzed by an M. tuberculosis-specific PCR assay (Cobas Amplicor; Roche), but this comparison was incomplete. In the Cobas Mtb PCR assay, only 0.1 ml of the clinical specimen is subjected to sample preparation for each test. However, this PCR assay includes an internal amplification control for each sample (23) , facilitating the monitoring of inhibitory factors in the clinical specimens.
Factors lowering the sensitivity of amplification techniques in general are interfering substances present in clinical specimens (7, 25, 27) . Inadequate amounts of the microbial DNA to be detected is a problem, especially as tuberculosis infections often are paucibacillary. An uneven distribution of bacteria or DNA, even after lysis of the material, as may apply particularly to the mucous material in sputum, can cause an arbitrary sampling effect.
The routine use of amplification techniques such as PCR and LCR to detect M. tuberculosis directly in clinical specimens has been hampered for a variety of reasons, such as lack of sensitivity and/or specificity, contamination problems, high expenses, and the relatively labor-intensive and complex procedures required for sample preparation, amplification, and detection (3, 7, 13, 25) . Our results indicate that, as with smear and culture analysis, more than one sample from each patient should be tested to allow sufficient accuracy of detection of M. tuberculosis in specimens by LCR. More automation and lower assay expenses, however, are required. Still, the LCx MTB Assay provides a sensitive and specific test for the M. tuberculosis complex that can be performed within 5 h, representing a valuable tool in routine mycobacterial diagnostics.
